Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YWHAZ | P63104 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14530930 | 1.00 | YWHAZ (1.00) | YWHAZ | |
| SCHEMBL14497663 | 1.00 | YWHAZ (1.00) | YWHAZ | |
| SCHEMBL13770407 | 1.00 | YWHAZ (1.00) | YWHAZ | |
| SCHEMBL14749536 | 1.00 | YWHAZ (1.00) | YWHAZ | |
| SCHEMBL29914208 | 1.00 | YWHAZ (1.00) | YWHAZ | |
| SCHEMBL14749541 | 0.94 | YWHAZ (0.90) | YWHAZ | |
| SCHEMBL14749566 | 0.94 | YWHAZ (0.89) | YWHAZ | |
| SCHEMBL26598089 | 0.94 | YWHAZ (0.88) | YWHAZ | |
| SCHEMBL13764968 | 0.90 | YWHAZ (0.81) | YWHAZ | |
| SCHEMBL26560757 | 0.89 | YWHAZ (0.80) | YWHAZ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| US-20240276934-A1 | LEAF VEIN ABSORPTION METHOD AND FUNCTIONAL MODIFICATION MATERIAL FOR PLANT | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2024-08-22 | — | — | US | claimed |
| US-20240174708-A1 | COMPOUNDS FOR TARGETED PROTEIN DEGRADATION | AMBAGON THERAPEUTICS INC (US) | 2024-05-30 | — | — | US | claimed |
| WO-2024069235-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2024-04-04 | — | — | WO | claimed |
| US-20240052015-A1 | INDUCIBLE SIGNALLING PROTEIN | Quell Therapeutics Limited (GB) | 2024-02-15 | — | — | US | claimed |
| EP-4267601-A1 | INDUCIBLE SIGNALLING PROTEIN | Quell Therapeutics Limited (GB) | 2023-11-01 | — | — | EP | claimed |
| WO-2023099886-A1 | SIGNALLING PROTEIN | Quell Therapeutics Limited (GB) | 2023-06-08 | — | — | WO | claimed |
| CN-114989997-A | Recombinant yarrowia lipolytica strain for high yield of sclareol and construction method and application thereof | 南京工业大学 | 2022-09-02 | — | — | CN | claimed |
| WO-2022136874-A1 | INDUCIBLE SIGNALLING PROTEIN | Quell Therapeutics Limited (GB) | 2022-06-30 | — | — | WO | claimed |
| EP-3852608-A1 | COMPOSITIONS AND METHODS FOR GLAUCOMA | Aufbau Medical Innovations Limited (IE) | 2021-07-28 | — | — | EP | claimed |
| EP-1599497-B1 | CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF 14-3-3, FUSICOCCIN, AND PLASMA MEMBRANE ATPASE AND METHODS FOR DESIGNING NEW HERBICIDES | MAX PLANCK GESELLSCHAFT (DE) | 2010-08-04 | — | — | EP | claimed |
| US-20090291905-A1 | FUNGAL PHYTOTOXIN FUSICOCCIN FOR THE TREATMENT AND DIAGNOSIS OF COAGULATION-CORRELATED PATHOLOGIES | UNIVERSITA' DEGLI STUDI DI ROMA "TOR VEGATA" (IT) | 2009-11-26 | — | — | US | claimed |
| US-20090215708-A1 | Treatment of Sexual Dysfunction with Proton Pump Agonists | GALER BRADLEY STUART | 2009-08-27 | — | — | US | claimed |
| US-7563825-B1 | Modulation of beta-catenin coactivator interactions to effect stem cell growth or differentiation | CHOONGWAE PHARMA CORPORATION (KR) | 2009-07-21 | — | — | US | claimed |
| US-7521538-B2 | Crystal structure of the ternary complex of 14-3-3/Fusicoccin/PMA and methods for designing new herbicides | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2009-04-21 | — | — | US | claimed |
| CN-101278616-A | Drought-resistant salt-alkali tolerant corn seed coating agent | XINJIANG GREENLAND SCIENCE AND (CN) | 2008-10-08 | — | — | CN | claimed |
| US-20070287629-A1 | Crystal structure of the ternary complex of 14-3-3/fusicoccin/pma and methods for designing new herbicides | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2007-12-13 | — | — | US | claimed |
| EP-1599497-A2 | CRYSTAL STRUCTURE OF THE TERNARY COMPELEX OF 14-3-3, FUSICOCCIN, AND PLASMA MEMBRANE ATPASE AND METHODS FOR DESIGNING NEW HERBICIDES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin (DE) | 2005-11-30 | — | — | EP | claimed |
| EP-0847241-B1 | INFLUENCING THE ACTIVITY OF PLANT GROWTH REGULATORS | PLANT RES INT BV (NL) | 2004-11-24 | — | — | EP | claimed |
| WO-2004075635-A2 | CRYSTAL STRUCTURE OF THE TERNARY COMPELEX OF 14-3-3, FUSICOCCIN AND PLASMA MEMBRANE ATPASE AND METHODS FOR DESIGNING NEW HERBICIDES | MAX-PLANCK-GESELLSCHAFT ZUR (DE) | 2004-09-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174708-A1 | COMPOUNDS FOR TARGETED PROTEIN DEGRADATION | STUB1, PSMG3, CUL3 | YWHAZ 151/4885 |
| US-20090215708-A1 | Treatment of Sexual Dysfunction with Proton Pump Agonists | GNRHR, HRH2, NSF | YWHAZ 4048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.